Defining neurocognitive impairment in HIV: Deficit scores versus clinical ratings

Clinical Neuropsychologist

Volumn 26, Issue 6, 2012, Pages 894-908

  Blackstone, K ^a   Moore, D J ^b   Franklin, D R ^b   Clifford, D B ^c   Collier, A C ^d   Marra, C M ^d   Gelman, B B ^e   McArthur, J C ^f   Morgello, S ^g   Simpson, D M ^g   Ellis, R J ^b   Atkinson, J H ^b,h   Grant, I ^b   Heaton, R K ^b  

^a SAN DIEGO STATE UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF WASHINGTON   (United States)

^e UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^f JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^h VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

Author keywords

Assessment; Cognition; Infectious disease

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS PROTEIN;

ADULT; ANALYSIS OF VARIANCE; ARTICLE; BLOOD; CHI SQUARE DISTRIBUTION; COGNITIVE DEFECT; DEPRESSION; FEMALE; GENETICS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; PSYCHOLOGICAL RATING SCALE; SEVERITY OF ILLNESS INDEX; VIROLOGY;

ADULT; ANALYSIS OF VARIANCE; CHI-SQUARE DISTRIBUTION; COGNITION DISORDERS; DEPRESSION; FEMALE; HIV; HIV INFECTIONS; HUMAN IMMUNODEFICIENCY VIRUS PROTEINS; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PSYCHIATRIC STATUS RATING SCALES; SEVERITY OF ILLNESS INDEX;

EID: 84871876872     PISSN: 13854046     EISSN: 17444144     Source Type: Journal    
DOI: 10.1080/13854046.2012.694479     Document Type: Article

References (23)

1. American Psychiatric Association (2000). Diagnostic and statistical manual of mental disorders (4th ed., text rev.). Washington, DC: APA.
2. Antinori, A., Arendt, G., Becker, J. T., Brew, B. J., Byrd, D. A., Cherner, M., et al. (2007). Updated research nosology for HIV-associated neurocognitive disorders. Neurology, 69(18), 1789-1799.
3. Beck, A. T., Steer, R. A., & Brown, G. K. (1996). Beck Depression Inventory-Second Edition Manual. San Antonio, TX: The Psychological Corporation.
4. Butters, N., Grant, I., Haxby, J., Judd, L. L., Martin, A., McClelland, J., et al. (1990). Assessment of Aids-related cognitive changes: Recommendations of NIMH workshop on neuropsychological assessment approaches. Journal of Clinical and Experimental Neuropsychology, 12(6), 963-978.
5. Carey, C., Woods, S. P., Gonzalez, R., Conover, E., Marcotte, T. D., Grant, I., et al. (2004). Predictive validity of Global Deficit Scores in detecting neuropsychological impairment in HIV infection. Journal of Clinical and Experimental Neuropsychology, 26(3), 307-319.
6. Chelune, G. J., Heaton, R. K., & Lehman, R. A. (1986). Neuropsychological and personality correlates of patients complaints of disability. New York: Plenum Press.
7. Gonzalez, R., Heaton, R. K., Moore, D. J., Letendre, S., Ellis, R., Wolfson, T., et al. for the HNRC Group (2003). Computerized reaction time battery versus a traditional neuropsychological battery: Detecting HIV-related impairments. Journal of the International Neuropsychological Society, 9, 64-71.
8. Heaton, R. K. (Clifford, D. B., Franklin, D. R., Woods, S. P., Ake, C, Vaida, F., et al. for the CHARTER Group (2010). HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study. Neurology, 75, 2087-2096.
9. Heaton, R. K., Franklin, D. R., Ellis, R. J., McCutchan, J. A., Letendre, S. L., Leblanc, S., et al. (2011). HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: Differences in rates, nature, and predictors. Journal of Neurovirology, 17(1), 3-16.
10. Heaton, R. K., Grant, I., Butters, N., White, D. A., Kirson, D., Atkinson, J. H., et al. for the HNRC Group (1995). The HNRC 500 - Neuropsychology of HIV infection at different disease stages. Journal of the International Neuropsychological Society, 1, 231-251.
11. Heaton, R. K., Kirson, D., Velin, R. A., Grant, I. the HNRC Group. (1994). The utility of clinical ratings for detecting cognitive change in HIV infection. In I. Grant & A. Markin (Eds.), Psychology of HIV infection (pp. 188-206). New York: Oxford University Press.
12. Heaton, R. K., Miller, S. W., Taylor, M. J., Grant, I. (2004). Revised comprehensive norms for an Expanded Halstead-Reitan Battery: Demographically adjusted for neuropsychological norms for African American and Caucasian adults. Lutz, FL: Psychological Assessment Resources.
13. Heaton, R. K., Velin, R. A., McCutchan, J. A., Cgulevich, S. J., Atkinson, J. H., Wallace, M. R., et al. for the HNRC Group (1994). Neuropsychological impairment in human immunodeficiency virus-infection: Implications for employment. Psychosomatic Medicine, 56, 8-17.
14. Heaton, R. K., Taylor, M. J., & Manly, J. (2003). Demographic effects and use of demographically corrected norms with the WAIS-III and WMS-III. In D. Tulsky et al. (Eds.), Clinical interpretation of the WAIS-III and WMS-III (pp. 181-210). Academic Press: London, UK.
15. Hinkin, C. H., Hardy, D. J., Mason, K. I., Castellon, S. A., Durvasula, R. S., Lam, M. N., et al. (2004). Medication adherence in HIV-infected adults: Effect of patient care, cognitive status, and substance abuse. AIDS, 18(Suppl 1), S19-S25.
16. Levine, A. J., Hinkin, C. H., Castellon, S. A., Mason, K. I., Lam, M. R., Perkins, A., et al. (2004). Variations in patterns of highly active antiretroviral therapy (HAART) adherence. AIDS and Behavior, 9(3), 355-362.
17. Malaspina, L., Woods, S. P., Moore, D. J., Depp, C., Letendre, S. L., Jeste, D., et al. for the HNRC Group (2011). Successful cognitive aging in persons living with HIV infection. Journal of Neurovirology, 77(1), 110-119.
18. Masliah, E., Heaton, R. K., Marcotte, T. D., Ellis, R. J., Wiley, C. A., Mallory, M., et al. (1997). Dendritic injury is a pathological substrate for human immunodeficiency virus-related cognitive disorders. Annals of Neurology, 42(6), 963-972.
19. Moore, D. J., Masliah, E., Rippeth, J. D., Gonzalez, R., Carey, C., Cherner, M., et al. (2006). Cortical and subcortical neurodegeneration is associated with HIV neurocognitive impairment. AIDS, 20(6), 879-887.
20. Norman, M. A., Moore, D. J., Taylor, M. J., Franklin, D., Cysique, L., Ake, C., et al. (2011). Demographically corrected norms for African Americans and Caucasians on the Hopkins Verbal Learning Test-Revised, Brief Visuospatial Memory Test-Revised, Stroop Color and Word Test, and Wisconsin Card Sorting Test 64-Card Version. Journal of Clinical and Experimental Neuropsychology, 4, 1-12.
21. Thames, A. D., Kim, M. S., Becker, B. W., Foley, J. M., Hines, L. J., Singer, E. J., et al. (2010). Medication and finance management among HIV-infected adults: The impact of age and cognition. Journal of Clinical and Experimental Neuropsychology, J First, 1-10.
22. Woods, S. P., Rippeth, J. D., Frol, A. B., Levy, J. K., Ryan, E., Soukup, V. M., et al. (2004). Interrater reliability of clinical ratings and neurocognitive diagnoses in HIV. Journal of Clinical and Experimental Neuropsychology, 26(6), 759-778.
23. Woods, S. P., Morgan, E. E., Dawson, M., Scott, J. C., & Grant, I. Group the HNRC (2006). Action (verb) fluency predicts dependence in instrumental activities of daily living in persons infected with HIV-1. Journal of Clinical and Experimental Neuropsychology, 28, 1030-1042.